Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9051 | 1191 | 26.6 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
329 | 3 | MENINGIOMA//NEUROSURG//JOURNAL OF NEURO-ONCOLOGY | 38091 |
1979 | 2 | BRAIN METASTASES//BRAIN METASTASIS//WHOLE BRAIN RADIOTHERAPY | 5613 |
9051 | 1 | NEOPLASTIC MENINGITIS//MENINGEAL CARCINOMATOSIS//LEPTOMENINGEAL CARCINOMATOSIS | 1191 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEOPLASTIC MENINGITIS | authKW | 1997563 | 8% | 84% | 93 |
2 | MENINGEAL CARCINOMATOSIS | authKW | 1826784 | 8% | 76% | 94 |
3 | LEPTOMENINGEAL CARCINOMATOSIS | authKW | 1656357 | 8% | 70% | 92 |
4 | LEPTOMENINGEAL METASTASIS | authKW | 1493704 | 7% | 69% | 85 |
5 | CARCINOMATOUS MENINGITIS | authKW | 1350722 | 6% | 75% | 70 |
6 | LEPTOMENINGEAL METASTASES | authKW | 1027479 | 6% | 60% | 67 |
7 | INTRATHECAL CHEMOTHERAPY | authKW | 615948 | 5% | 41% | 58 |
8 | LIPOSOMAL CYTARABINE | authKW | 558300 | 2% | 78% | 28 |
9 | INTRAVENTRICULAR CHEMOTHERAPY | authKW | 283975 | 1% | 92% | 12 |
10 | LEPTOMENINGEAL DISEASE | authKW | 235515 | 2% | 44% | 21 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 7568 | 35% | 0% | 418 |
2 | Oncology | 7519 | 41% | 0% | 494 |
3 | Pathology | 889 | 8% | 0% | 99 |
4 | Medical Laboratory Technology | 710 | 4% | 0% | 51 |
5 | Neuroimaging | 408 | 2% | 0% | 29 |
6 | Radiology, Nuclear Medicine & Medical Imaging | 190 | 6% | 0% | 73 |
7 | Hematology | 186 | 5% | 0% | 55 |
8 | Medicine, General & Internal | 161 | 7% | 0% | 84 |
9 | Surgery | 158 | 8% | 0% | 100 |
10 | Neurosciences | 121 | 8% | 0% | 101 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNI S DIAGNOST | 76910 | 0% | 100% | 3 |
2 | NEUROL BREAST UNIT | 51274 | 0% | 100% | 2 |
3 | NEUROONCOL CLIN | 39919 | 1% | 17% | 9 |
4 | NEUROONCOL MAZARIN | 34181 | 0% | 67% | 2 |
5 | NEUROONCOL | 28089 | 4% | 2% | 52 |
6 | ADOLESCENTS YOUNG ADULT UNIT | 25637 | 0% | 100% | 1 |
7 | AUSTIN BRAIN TUMOR | 25637 | 0% | 100% | 1 |
8 | BRAIN TUMOR S80 | 25637 | 0% | 100% | 1 |
9 | CANC THER Y SAN ANTONIO | 25637 | 0% | 100% | 1 |
10 | CFMPB | 25637 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURO-ONCOLOGY | 74309 | 10% | 2% | 125 |
2 | ACTA CYTOLOGICA | 5225 | 3% | 1% | 31 |
3 | DIAGNOSTIC CYTOPATHOLOGY | 1931 | 2% | 0% | 18 |
4 | CANCER | 1740 | 4% | 0% | 44 |
5 | JOURNAL OF CLINICAL NEUROSCIENCE | 1389 | 2% | 0% | 18 |
6 | CYTOMETRY PART B-CLINICAL CYTOMETRY | 1316 | 1% | 1% | 6 |
7 | JOURNAL OF CLINICAL ONCOLOGY | 1286 | 2% | 0% | 29 |
8 | NEUROLOGY | 1190 | 3% | 0% | 32 |
9 | ARCHIVES OF NEUROLOGY | 969 | 1% | 0% | 16 |
10 | LUNG CANCER | 956 | 1% | 0% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHAMBERLAIN, MC , (2010) LEPTOMENINGEAL METASTASIS.CURRENT OPINION IN ONCOLOGY. VOL. 22. ISSUE 6. P. 627 -635 | 80 | 92% | 50 |
2 | CHAMBERLAIN, MC , (2009) LEPTOMENINGEAL METASTASIS.CURRENT OPINION IN NEUROLOGY. VOL. 22. ISSUE 6. P. 665-674 | 80 | 94% | 17 |
3 | CHAMBERLAIN, MC , (2008) NEOPLASTIC MENINGITIS.ONCOLOGIST. VOL. 13. ISSUE 9. P. 967-977 | 70 | 95% | 48 |
4 | CHAMBERLAIN, MC , (2010) LEPTOMENINGEAL METASTASIS.SEMINARS IN NEUROLOGY. VOL. 30. ISSUE 3. P. 236-244 | 66 | 96% | 19 |
5 | TAILLIBERT, S , LAIGLE-DONADEY, F , CHODKIEWICZ, C , SANSON, M , HOANG-XUAN, K , DELATTRE, JY , (2005) LEPTOMENINGEAL METASTASES FROM SOLID MALIGNANCY: A REVIEW.JOURNAL OF NEURO-ONCOLOGY. VOL. 75. ISSUE 1. P. 85 -99 | 94 | 68% | 60 |
6 | CHAMBERLAIN, MC , (2005) NEOPLASTIC MENINGITIS (RETRACTED ARTICLE. SEE VOL. 28, PG 4018, 2010).JOURNAL OF CLINICAL ONCOLOGY. VOL. 23. ISSUE 15. P. 3605 -3613 | 65 | 94% | 81 |
7 | CHAMBERLAIN, MC , (2008) NEOPLASTIC MENINGITIS.CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. VOL. 8. ISSUE 3. P. 249 -258 | 66 | 94% | 9 |
8 | O'MEARA, WP , BORKAR, SA , STAMBUK, HE , LYMBERIS, SC , (2007) LEPTOMENINGEAL METASTASIS.CURRENT PROBLEMS IN CANCER. VOL. 31. ISSUE 6. P. 372-424 | 102 | 63% | 2 |
9 | CHAMBERLAIN, MC , (2006) NEOPLASTIC MENINGITIS.NEUROLOGIST. VOL. 12. ISSUE 4. P. 179 -187 | 65 | 94% | 28 |
10 | BOOGERD, W , (2007) LEPTOMENINGEAL METASTASIS IN SOLID TUMOURS: IS THERE A ROLE FOR INTRATHECAL THERAPY?.EJC SUPPLEMENTS. VOL. 5. ISSUE 5. P. 41 -51 | 68 | 88% | 2 |
Classes with closest relation at Level 1 |